Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2013

01-08-2013 | Review

Paget’s disease of the nipple

Authors: Ana C. Sandoval-Leon, Katherine Drews-Elger, Carmen R. Gomez-Fernandez, Monica M. Yepes, Marc E. Lippman

Published in: Breast Cancer Research and Treatment | Issue 1/2013

Login to get access

Abstract

Paget’s disease of the breast is a disorder of the nipple–areola complex that, while rare, is often associated with an underlying carcinoma. It is characterized by eczematoid changes of the nipple. Two theories have been proposed to explain the pathogenesis of Paget’s disease. The Epidermotropic, which is the most accepted theory, suggests that Paget’s cells originate from ductal cancer cells that had migrated from the underlying breast parenchyma. It is supported by the predominance of breast cancer markers found in Paget’s disease. This article provides an overview of Paget’s disease of the breast with special attention to immunohistochemistry and raises the question of new therapeutic approaches.
Literature
2.
go back to reference Lim HS, Jeong SJ, Lee JS, Park MH, Kim JW, Shin SS, Park JG, Kang HK (2011) Paget disease of the breast: mammographic, US, and MR imaging findings with pathologic correlation. Radiographics 31(7):1973–1987. doi:10.1148/rg.317115070 PubMedCrossRef Lim HS, Jeong SJ, Lee JS, Park MH, Kim JW, Shin SS, Park JG, Kang HK (2011) Paget disease of the breast: mammographic, US, and MR imaging findings with pathologic correlation. Radiographics 31(7):1973–1987. doi:10.​1148/​rg.​317115070 PubMedCrossRef
4.
go back to reference Graham H (1939) The story of surgery, vol 24. Doubleday Doran, New York Graham H (1939) The story of surgery, vol 24. Doubleday Doran, New York
5.
go back to reference Velpeau A (1856) A treatise on the disease of the breast and mammary region. Sydenham society, London Velpeau A (1856) A treatise on the disease of the breast and mammary region. Sydenham society, London
6.
go back to reference Caliskan M, Gatti G, Sosnovskikh I, Rotmensz N, Botteri E, Musmeci S, Rosali dos Santos G, Viale G, Luini A (2008) Paget’s disease of the breast: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat 112(3):513–521. doi:10.1007/s10549-007-9880-5 PubMedCrossRef Caliskan M, Gatti G, Sosnovskikh I, Rotmensz N, Botteri E, Musmeci S, Rosali dos Santos G, Viale G, Luini A (2008) Paget’s disease of the breast: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat 112(3):513–521. doi:10.​1007/​s10549-007-9880-5 PubMedCrossRef
7.
go back to reference Paget J (1874) On disease of mammary areola preceding cancer of the mammary gland. St Bartholemew Hospital Res Lond 10:87–89 Paget J (1874) On disease of mammary areola preceding cancer of the mammary gland. St Bartholemew Hospital Res Lond 10:87–89
9.
go back to reference Kawase K, Dimaio DJ, Tucker SL, Buchholz TA, Ross MI, Feig BW, Kuerer HM, Meric-Bernstam F, Babiera G, Ames FC, Singletary SE, Hunt KK (2005) Paget’s disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol 12(5):391–397. doi:10.1245/aso.2005.05.026 PubMedCrossRef Kawase K, Dimaio DJ, Tucker SL, Buchholz TA, Ross MI, Feig BW, Kuerer HM, Meric-Bernstam F, Babiera G, Ames FC, Singletary SE, Hunt KK (2005) Paget’s disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol 12(5):391–397. doi:10.​1245/​aso.​2005.​05.​026 PubMedCrossRef
10.
go back to reference Lohsiriwat V, Martella S, Rietjens M, Botteri E, Rotmensz N, Mastropasqua MG, Garusi C, De Lorenzi F, Manconi A, Sommario M, Barbieri B, Cassilha M, Minotti I, Petit JY (2012) Paget’s disease as a local recurrence after nipple-sparing mastectomy: clinical presentation, treatment, outcome, and risk factor analysis. Ann Surg Oncol 19(6):1850–1855. doi:10.1245/s10434-012-2226-5 PubMedCrossRef Lohsiriwat V, Martella S, Rietjens M, Botteri E, Rotmensz N, Mastropasqua MG, Garusi C, De Lorenzi F, Manconi A, Sommario M, Barbieri B, Cassilha M, Minotti I, Petit JY (2012) Paget’s disease as a local recurrence after nipple-sparing mastectomy: clinical presentation, treatment, outcome, and risk factor analysis. Ann Surg Oncol 19(6):1850–1855. doi:10.​1245/​s10434-012-2226-5 PubMedCrossRef
13.
18.
go back to reference Fu W, Mittel VK, Young SC (2001) Paget disease of the breast: analysis of 41 patients. Am J Clin Oncol 24(4):397–400PubMedCrossRef Fu W, Mittel VK, Young SC (2001) Paget disease of the breast: analysis of 41 patients. Am J Clin Oncol 24(4):397–400PubMedCrossRef
19.
go back to reference Tanaka VD, Sanches JA, Torezan L, Niwa AB, Festa Neto C (2009) Mammary and extramammary Paget’s disease: a study of 14 cases and the associated therapeutic difficulties. Clinics (Sao Paulo, Brazil) 64(6):599–606 Tanaka VD, Sanches JA, Torezan L, Niwa AB, Festa Neto C (2009) Mammary and extramammary Paget’s disease: a study of 14 cases and the associated therapeutic difficulties. Clinics (Sao Paulo, Brazil) 64(6):599–606
23.
go back to reference Gubitosi A, Moccia G, Malinconico FA, Iside G, Gilio F, Cognetti C, Foroni F, Docimo G, Ruggiero R, Docimo L, Agresti M (2009) Metachronous Paget’s disease of the breast: case report. Il Giornale di chirurgia 30(4):153–155PubMed Gubitosi A, Moccia G, Malinconico FA, Iside G, Gilio F, Cognetti C, Foroni F, Docimo G, Ruggiero R, Docimo L, Agresti M (2009) Metachronous Paget’s disease of the breast: case report. Il Giornale di chirurgia 30(4):153–155PubMed
32.
go back to reference Mrhalova M, Kodet R (2003) Paget’s disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1. Neoplasma 50(6):396–402PubMed Mrhalova M, Kodet R (2003) Paget’s disease of the nipple: a copy number of the genes ERBB2 and CCND1 versus expression of the proteins ERBB-2 and cyclin D1. Neoplasma 50(6):396–402PubMed
34.
go back to reference Crocker HR (1889) Pemphigus Vegetans (Neumann). Medico-chirurgical Trans 72(233–256):231 Crocker HR (1889) Pemphigus Vegetans (Neumann). Medico-chirurgical Trans 72(233–256):231
35.
go back to reference Sanders MA, Dominici L, Denison C, Golshan M, Wiecorek T, Lester SC (2013) Paget disease of the breast with invasion from nipple skin into the dermis: an unusual type of skin invasion not associated with an adverse outcome. Arch Pathol Lab Med 137(1):72–76. doi:10.5858/arpa.2011-0611-OA PubMedCrossRef Sanders MA, Dominici L, Denison C, Golshan M, Wiecorek T, Lester SC (2013) Paget disease of the breast with invasion from nipple skin into the dermis: an unusual type of skin invasion not associated with an adverse outcome. Arch Pathol Lab Med 137(1):72–76. doi:10.​5858/​arpa.​2011-0611-OA PubMedCrossRef
37.
go back to reference Marczyk E, Kruczak A, Ambicka A, Mularz K, Harazin-Lechowska A, Moskal J, Sokolowski A, Mitus J, Rys J (2011) The routine immunohistochemical evaluation in Paget disease of the nipple. Polish J Pathol 62(4):229–235 Marczyk E, Kruczak A, Ambicka A, Mularz K, Harazin-Lechowska A, Moskal J, Sokolowski A, Mitus J, Rys J (2011) The routine immunohistochemical evaluation in Paget disease of the nipple. Polish J Pathol 62(4):229–235
39.
go back to reference Duan X, Sneige N, Gullett AE, Prieto VG, Resetkova E, Andino LM, Wu Y, Gilcrease MZ, Bedrosian I, Dawood S, Arun B, Albarracin CT (2012) Invasive Paget disease of the breast: clinicopathologic study of an underrecognized entity in the breast. Am J Surg Pathol 36(9):1353–1358. doi:10.1097/PAS.0b013e318259ef7f PubMedCrossRef Duan X, Sneige N, Gullett AE, Prieto VG, Resetkova E, Andino LM, Wu Y, Gilcrease MZ, Bedrosian I, Dawood S, Arun B, Albarracin CT (2012) Invasive Paget disease of the breast: clinicopathologic study of an underrecognized entity in the breast. Am J Surg Pathol 36(9):1353–1358. doi:10.​1097/​PAS.​0b013e318259ef7f​ PubMedCrossRef
40.
go back to reference Soler T, Lerin A, Serrano T, Masferrer E, Garcia-Tejedor A, Condom E (2011) Pigmented Paget disease of the breast nipple with underlying infiltrating carcinoma: a case report and review of the literature. Am J Dermatopathol 33(5):e54–e57. doi:10.1097/DAD.0b013e3181fd1eec PubMedCrossRef Soler T, Lerin A, Serrano T, Masferrer E, Garcia-Tejedor A, Condom E (2011) Pigmented Paget disease of the breast nipple with underlying infiltrating carcinoma: a case report and review of the literature. Am J Dermatopathol 33(5):e54–e57. doi:10.​1097/​DAD.​0b013e3181fd1eec​ PubMedCrossRef
42.
go back to reference Anderson JM, Ariga R, Govil H, Bloom KJ, Francescatti D, Reddy VB, Gould VE, Gattuso P (2003) Assessment of Her-2/Neu status by immunohistochemistry and fluorescence in situ hybridization in mammary Paget disease and underlying carcinoma. AIMM 11(2):120–124PubMed Anderson JM, Ariga R, Govil H, Bloom KJ, Francescatti D, Reddy VB, Gould VE, Gattuso P (2003) Assessment of Her-2/Neu status by immunohistochemistry and fluorescence in situ hybridization in mammary Paget disease and underlying carcinoma. AIMM 11(2):120–124PubMed
43.
go back to reference Fu W, Lobocki CA, Silberberg BK, Chelladurai M, Young SC (2001) Molecular markers in Paget disease of the breast. J Surg Oncol 77(3):171–178PubMedCrossRef Fu W, Lobocki CA, Silberberg BK, Chelladurai M, Young SC (2001) Molecular markers in Paget disease of the breast. J Surg Oncol 77(3):171–178PubMedCrossRef
44.
go back to reference Hanna W, Alowami S, Malik A (2003) The role of HER-2/neu oncogene and vimentin filaments in the production of the Paget’s phenotype. Breast J 9(6):485–490PubMedCrossRef Hanna W, Alowami S, Malik A (2003) The role of HER-2/neu oncogene and vimentin filaments in the production of the Paget’s phenotype. Breast J 9(6):485–490PubMedCrossRef
45.
go back to reference Kothari AS, Beechey-Newman N, Hamed H, Fentiman IS, D’Arrigo C, Hanby AM, Ryder K (2002) Paget disease of the nipple: a multifocal manifestation of higher-risk disease. Cancer 95(1):1–7. doi:10.1002/cncr.10638 PubMedCrossRef Kothari AS, Beechey-Newman N, Hamed H, Fentiman IS, D’Arrigo C, Hanby AM, Ryder K (2002) Paget disease of the nipple: a multifocal manifestation of higher-risk disease. Cancer 95(1):1–7. doi:10.​1002/​cncr.​10638 PubMedCrossRef
46.
go back to reference Lester T, Wang J, Bourne P, Yang Q, Fu L, Tang P (2009) Different panels of markers should be used to predict mammary Paget’s disease associated with in situ or invasive ductal carcinoma of the breast. Ann Clin Lab Sci 39(1):17–24PubMed Lester T, Wang J, Bourne P, Yang Q, Fu L, Tang P (2009) Different panels of markers should be used to predict mammary Paget’s disease associated with in situ or invasive ductal carcinoma of the breast. Ann Clin Lab Sci 39(1):17–24PubMed
48.
go back to reference Schelfhout VR, Coene ED, Delaey B, Thys S, Page DL, De Potter CR (2000) Pathogenesis of Paget’s disease: epidermal heregulin-alpha, motility factor, and the HER receptor family. J Natl Cancer Inst 92(8):622–628PubMedCrossRef Schelfhout VR, Coene ED, Delaey B, Thys S, Page DL, De Potter CR (2000) Pathogenesis of Paget’s disease: epidermal heregulin-alpha, motility factor, and the HER receptor family. J Natl Cancer Inst 92(8):622–628PubMedCrossRef
49.
50.
go back to reference Fromowitz FB, Viola MV, Chao S, Oravez S, Mishriki Y, Finkel G, Grimson R, Lundy J (1987) ras p21 expression in the progression of breast cancer. Hum Pathol 18(12):1268–1275PubMedCrossRef Fromowitz FB, Viola MV, Chao S, Oravez S, Mishriki Y, Finkel G, Grimson R, Lundy J (1987) ras p21 expression in the progression of breast cancer. Hum Pathol 18(12):1268–1275PubMedCrossRef
51.
go back to reference Mori O, Hachisuka H, Nakano S, Sasai Y, Shiku H (1990) Expression of ras p21 in mammary and extramammary Paget’s disease. Arch Pathol Lab Med 114(8):858–861PubMed Mori O, Hachisuka H, Nakano S, Sasai Y, Shiku H (1990) Expression of ras p21 in mammary and extramammary Paget’s disease. Arch Pathol Lab Med 114(8):858–861PubMed
52.
go back to reference Ellis PE, Fong LF, Rolfe KJ, Crow JC, Reid WM, Davidson T, MacLean AB, Perrett CW (2002) The role of p53 and Ki67 in Paget’s disease of the vulva and the breast. Gynecol Oncol 86(2):150–156PubMedCrossRef Ellis PE, Fong LF, Rolfe KJ, Crow JC, Reid WM, Davidson T, MacLean AB, Perrett CW (2002) The role of p53 and Ki67 in Paget’s disease of the vulva and the breast. Gynecol Oncol 86(2):150–156PubMedCrossRef
53.
go back to reference Buxant F, Noel JC (2008) Pl6 expression in Paget’s disease of the breast. Eur J Gynaecol Oncol 29(5):441–443PubMed Buxant F, Noel JC (2008) Pl6 expression in Paget’s disease of the breast. Eur J Gynaecol Oncol 29(5):441–443PubMed
54.
go back to reference Czerwenka K, Heuss F, Hosmann JW, Manavi M, Lu Y, Jelincic D, Kubista E (1996) Human papilloma virus DNA: a factor in the pathogenesis of mammary Paget’s disease? Breast Cancer Res Treat 41(1):51–57PubMedCrossRef Czerwenka K, Heuss F, Hosmann JW, Manavi M, Lu Y, Jelincic D, Kubista E (1996) Human papilloma virus DNA: a factor in the pathogenesis of mammary Paget’s disease? Breast Cancer Res Treat 41(1):51–57PubMedCrossRef
56.
go back to reference Lau J, Kohler S (2003) Keratin profile of intraepidermal cells in Paget’s disease, extramammary Paget’s disease, and pagetoid squamous cell carcinoma in situ. J Cutan Pathol 30(7):449–454PubMedCrossRef Lau J, Kohler S (2003) Keratin profile of intraepidermal cells in Paget’s disease, extramammary Paget’s disease, and pagetoid squamous cell carcinoma in situ. J Cutan Pathol 30(7):449–454PubMedCrossRef
58.
go back to reference Kuan SF, Montag AG, Hart J, Krausz T, Recant W (2001) Differential expression of mucin genes in mammary and extramammary Paget’s disease. Am J Surg Pathol 25(12):1469–1477PubMedCrossRef Kuan SF, Montag AG, Hart J, Krausz T, Recant W (2001) Differential expression of mucin genes in mammary and extramammary Paget’s disease. Am J Surg Pathol 25(12):1469–1477PubMedCrossRef
60.
go back to reference Kondo Y, Kashima K, Daa T, Fujiwara S, Nakayama I, Yokoyama S (2002) The ectopic expression of gastric mucin in extramammary and mammary Paget’s disease. Am J Surg Pathol 26(5):617–623PubMedCrossRef Kondo Y, Kashima K, Daa T, Fujiwara S, Nakayama I, Yokoyama S (2002) The ectopic expression of gastric mucin in extramammary and mammary Paget’s disease. Am J Surg Pathol 26(5):617–623PubMedCrossRef
61.
go back to reference Vielh P, Validire P, Kheirallah S, Campana F, Fourquet A, Di Bonito L (1993) Paget’s disease of the nipple without clinically and radiologically detectable breast tumor. Histochemical and immunohistochemical study of 44 cases. Pathol Res Pract 189(2):150–155. doi:10.1016/s0344-0338(11)80085-3 PubMedCrossRef Vielh P, Validire P, Kheirallah S, Campana F, Fourquet A, Di Bonito L (1993) Paget’s disease of the nipple without clinically and radiologically detectable breast tumor. Histochemical and immunohistochemical study of 44 cases. Pathol Res Pract 189(2):150–155. doi:10.​1016/​s0344-0338(11)80085-3 PubMedCrossRef
64.
go back to reference Soini Y (2004) Claudins 2,3,4, and 5 in Paget’s disease and breast carcinoma. Hum Pathol 35(12):1531–1536PubMedCrossRef Soini Y (2004) Claudins 2,3,4, and 5 in Paget’s disease and breast carcinoma. Hum Pathol 35(12):1531–1536PubMedCrossRef
65.
go back to reference de Azambuja E, Cardoso F, de Castro G, Jr, Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M (2007) Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer 96(10):1504–1513. doi:10.1038/sj.bjc.6603756 de Azambuja E, Cardoso F, de Castro G, Jr, Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M (2007) Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer 96(10):1504–1513. doi:10.​1038/​sj.​bjc.​6603756
66.
go back to reference Jung SY, Han W, Lee JW, Ko E, Kim E, Yu JH, Moon HG, Park IA, Oh DY, Im SA, Kim TY, Hwang KT, Kim SW, Noh DY (2009) Ki-67 expression gives additional prognostic information on St. Gallen 2007 and Adjuvant! Online risk categories in early breast cancer. Ann Surg Oncol 16(5):1112–1121. doi:10.1245/s10434-009-0334-7 PubMedCrossRef Jung SY, Han W, Lee JW, Ko E, Kim E, Yu JH, Moon HG, Park IA, Oh DY, Im SA, Kim TY, Hwang KT, Kim SW, Noh DY (2009) Ki-67 expression gives additional prognostic information on St. Gallen 2007 and Adjuvant! Online risk categories in early breast cancer. Ann Surg Oncol 16(5):1112–1121. doi:10.​1245/​s10434-009-0334-7 PubMedCrossRef
67.
go back to reference Inwald EC, Klinkhammer-Schalke M, Hofstadter F, Zeman F, Koller M, Gerstenhauer M, Ortmann O (2013) Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat 139(2):539–552. doi:10.1007/s10549-013-2560-8 PubMedCentralPubMedCrossRef Inwald EC, Klinkhammer-Schalke M, Hofstadter F, Zeman F, Koller M, Gerstenhauer M, Ortmann O (2013) Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat 139(2):539–552. doi:10.​1007/​s10549-013-2560-8 PubMedCentralPubMedCrossRef
70.
71.
72.
go back to reference Marucci G, Betts CM, Golouh R, Peterse JL, Foschini MP, Eusebi V (2002) Toker cells are probably precursors of Paget cell carcinoma: a morphological and ultrastructural description. Virchows Archiv 441(2):117–123. doi:10.1007/s00428-001-0581-x PubMedCrossRef Marucci G, Betts CM, Golouh R, Peterse JL, Foschini MP, Eusebi V (2002) Toker cells are probably precursors of Paget cell carcinoma: a morphological and ultrastructural description. Virchows Archiv 441(2):117–123. doi:10.​1007/​s00428-001-0581-x PubMedCrossRef
73.
go back to reference Morandi L, Pession A, Marucci GL, Foschini MP, Pruneri G, Viale G, Eusebi V (2003) Intraepidermal cells of Paget’s carcinoma of the breast can be genetically different from those of the underlying carcinoma. Hum Pathol 34(12):1321–1330PubMedCrossRef Morandi L, Pession A, Marucci GL, Foschini MP, Pruneri G, Viale G, Eusebi V (2003) Intraepidermal cells of Paget’s carcinoma of the breast can be genetically different from those of the underlying carcinoma. Hum Pathol 34(12):1321–1330PubMedCrossRef
74.
go back to reference Berg W, Birdwell RL (2006) Diagnostic imaging: breast. Amirsys Berg W, Birdwell RL (2006) Diagnostic imaging: breast. Amirsys
75.
go back to reference Ikeda DM, Helvie MA, Frank TS, Chapel KL, Andersson IT (1993) Paget disease of the nipple: radiologic-pathologic correlation. Radiology 189(1):89–94PubMedCrossRef Ikeda DM, Helvie MA, Frank TS, Chapel KL, Andersson IT (1993) Paget disease of the nipple: radiologic-pathologic correlation. Radiology 189(1):89–94PubMedCrossRef
79.
go back to reference Frei KA, Bonel HM, Pelte MF, Hylton NM, Kinkel K (2005) Paget disease of the breast: findings at magnetic resonance imaging and histopathologic correlation. Invest Radiol 40(6):363–367PubMedCrossRef Frei KA, Bonel HM, Pelte MF, Hylton NM, Kinkel K (2005) Paget disease of the breast: findings at magnetic resonance imaging and histopathologic correlation. Invest Radiol 40(6):363–367PubMedCrossRef
81.
go back to reference Marshall JK, Griffith KA, Haffty BG, Solin LJ, Vicini FA, McCormick B, Wazer DE, Recht A, Pierce LJ (2003) Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results. Cancer 97(9):2142–2149. doi:10.1002/cncr.11337 PubMedCrossRef Marshall JK, Griffith KA, Haffty BG, Solin LJ, Vicini FA, McCormick B, Wazer DE, Recht A, Pierce LJ (2003) Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results. Cancer 97(9):2142–2149. doi:10.​1002/​cncr.​11337 PubMedCrossRef
83.
go back to reference Bijker N, Rutgers EJ, Duchateau L, Peterse JL, Julien JP, Cataliotti L (2001) Breast-conserving therapy for Paget disease of the nipple: a prospective European Organization for Research and Treatment of Cancer study of 61 patients. Cancer 91(3):472–477PubMedCrossRef Bijker N, Rutgers EJ, Duchateau L, Peterse JL, Julien JP, Cataliotti L (2001) Breast-conserving therapy for Paget disease of the nipple: a prospective European Organization for Research and Treatment of Cancer study of 61 patients. Cancer 91(3):472–477PubMedCrossRef
85.
go back to reference Onoe S, Kinoshita T, Tamura N, Nagao T, Kuno H, Hojo T, Akashi-Tanaka S, Tsuda H (2011) Feasibility of breast conserving surgery for Paget’s disease. Breast (Edinburgh, Scotland) 20(6):515–518. doi:10.1016/j.breast.2011.05.010 Onoe S, Kinoshita T, Tamura N, Nagao T, Kuno H, Hojo T, Akashi-Tanaka S, Tsuda H (2011) Feasibility of breast conserving surgery for Paget’s disease. Breast (Edinburgh, Scotland) 20(6):515–518. doi:10.​1016/​j.​breast.​2011.​05.​010
87.
88.
go back to reference Marcus E (2004) The management of Paget’s disease of the breast. Curr Treat Options Oncol 5(2):153–160PubMedCrossRef Marcus E (2004) The management of Paget’s disease of the breast. Curr Treat Options Oncol 5(2):153–160PubMedCrossRef
89.
go back to reference Network NCC (2013) NCCN clinical practice guidelines in oncology. Breast Cancer Version 2 Network NCC (2013) NCCN clinical practice guidelines in oncology. Breast Cancer Version 2
90.
go back to reference Ortiz-Pagan S, Cunto-Amesty G, Narayan S, Crawford S, Derrick C, Larkin A, Khan A, Quinlan R, Layeequr Rahman R (2011) Effect of Paget’s disease on survival in breast cancer: an exploratory study. Arch Surg (Chicago, Ill: 1960) 146(11):1267–1270. doi:10.1001/archsurg.2011.278 Ortiz-Pagan S, Cunto-Amesty G, Narayan S, Crawford S, Derrick C, Larkin A, Khan A, Quinlan R, Layeequr Rahman R (2011) Effect of Paget’s disease on survival in breast cancer: an exploratory study. Arch Surg (Chicago, Ill: 1960) 146(11):1267–1270. doi:10.​1001/​archsurg.​2011.​278
Metadata
Title
Paget’s disease of the nipple
Authors
Ana C. Sandoval-Leon
Katherine Drews-Elger
Carmen R. Gomez-Fernandez
Monica M. Yepes
Marc E. Lippman
Publication date
01-08-2013
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2013
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2661-4

Other articles of this Issue 1/2013

Breast Cancer Research and Treatment 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine